Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Filings indexed 351 across all filing types
Latest filing 2024-12-13 Regulatory Filings
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Telcon RF Pharmaceutical regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 26th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action (setting a record date). Given the nature of the announcement as a regulatory disclosure of a procedural step for an upcoming meeting, it fits best under the general regulatory filing category.
2024-12-13 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from Telcon RF Pharmaceutical. It details the completion of a private placement of exchangeable bonds (사모 교환사채). This falls under the category of company fundraising and financing activities, which corresponds to the 'Capital/Financing Update' (CAP) category.
2024-12-12 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from Telcon RF Pharmaceutical. It details the completion of a private placement of exchangeable bonds (2.5 billion KRW). Since this document reports on the outcome of a financing activity (issuance of debt securities), it falls under the 'Capital/Financing Update' category.
2024-12-12 Korean
주요사항보고서(교환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (FSS/KRX) regarding the issuance of exchangeable bonds (교환사채권 발행결정). This type of regulatory filing details specific corporate financing activities, including terms of the bond, interest rates, and use of proceeds. It falls under the category of capital and financing updates.
2024-12-11 Korean
주요사항보고서(교환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Exchangeable Bonds' (교환사채권 발행결정). This document outlines the terms of a financing activity, including bond amounts, interest rates, conversion details, and the use of proceeds. According to the filing definitions, documents related to company fundraising, financing activities, or capital structure changes are classified as 'CAP' (Capital/Financing Update).
2024-12-11 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from Telcon RF Pharmaceutical regarding the acquisition of shares in another company (Abion Inc.). It is a 'Correction Report' (정정신고) updating the expected acquisition date. This type of disclosure regarding corporate investment, asset acquisition, and capital structure changes falls under the category of M&A Activity (TAR) or general regulatory filings. Given the specific nature of the 'Acquisition of shares and equity securities of other corporations' (타법인 주식 및 출자증권 취득결정), it is best classified as M&A Activity.
2024-12-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.